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Abstract
Background: Angiogenesis is crucial to many physiological and pathological processes including development and cancer
cell survival. Vascular endothelial growth factor-A (VEGFA) is the predominant mediator of angiogenesis in the VEGF family.
During development, adverse environmental conditions like nutrient deprivation, hypoxia and increased protein secretion
occur. IRE1a, PERK, and ATF6a, master regulators of the unfolded protein response (UPR), are activated under these
conditions and are proposed to have a role in mediating angiogenesis.
Principal Findings: Here we show that IRE1a, PERK, and ATF6a powerfully regulate VEGFA mRNA expression under various
stress conditions. In Ire1a2/2 and Perk2/2 mouse embryonic fibroblasts and ATF6a-knockdown HepG2 cells, induction of
VEGFA mRNA by endoplasmic reticulum stress is attenuated as compared to control cells. Embryonic lethality of Ire1a2/2
mice is due to the lack of VEGFA induction in labyrinthine trophoblast cells of the developing placenta. Rescue of IRE1a and
PERK in Ire1a2/2 and Perk2/2 cells respectively, prevents VEGFA mRNA attenuation. We further report that the induction of
VEGFA by IRE1a, PERK and ATF6 involves activation of transcription factors, spliced-XBP-1, ATF4 and cleaved ATF6
respectively.
Conclusions/Significance: Our results reveal that the IRE1a-XBP-1, PERK-ATF4, and ATF6a pathways constitute novel
upstream regulatory pathways of angiogenesis by modulating VEGF transcription. Activation of these pathways helps the
rapidly growing cells to obtain sufficient nutrients and growth factors for their survival under the prevailing hostile
environmental conditions. These results establish an important role of the UPR in angiogenesis.
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Introduction
Productive folding of secretory proteins in the endoplasmic
reticulum (ER) is essential to ensure normal cell function. In
order for secretory proteins to fold properly, ER homeostasis
must be maintained. ER homeostasis is defined by the dynamic
balance between the ER protein load and the ER capacity to
process this load. ER homeostasis can be perturbed by
pathological processes such as hypoxia, glucose deprivation,
viral infections, environmental toxins, inflammatory cytokines,
and mutant protein expression, as well as by physiological
processes such as aging. Disruption of ER homeostasis causes
accumulation of unfolded and misfolded proteins in the ER.
This condition is referred to as ER stress. Cells cope with ER
stress by activating the Unfolded Protein Response (UPR) [1,2].
The UPR is initiated by three ER transmembrane proteins:
Inositol Requiring 1 (IRE1), PKR-like ER kinase (PERK), and
Activating Transcription Factor 6 (ATF6). These three master
regulators sense and interpret protein folding conditions in the
ER and translate this information across the ER membrane to
regulate downstream effectors. These effectors have two distinct
outputs, homeostatic and apoptotic. Homeostatic outputs are
adaptive responses that function to attenuate ER stress and
restore ER homeostasis. These responses include the attenua-
tion of protein translation to reduce ER workload and prevent
further accumulation of unfolded proteins, upregulation of
molecular chaperones and protein processing enzymes to
enhance the ER folding activity, and the increase in ER-
associated degradation (ERAD) components to promote clear-
ance of unfolded proteins. When ER stress reaches a point
where the cells cannot tolerate the load of unfolded proteins any
more, apoptosis sets in [1].
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Recent studies have indicated that cells suffering from
insufficient blood supplies experience ER stress. The ER needs
energy and oxygen for the folding process, thus nutrient
deprivation (low ATP production) and hypoxia caused by
insufficient blood supply leads to inefficient protein folding and
ER stress in cells, especially in cancer cells that grow and
spread rapidly [3,4,5]. This condition also occurs in the
development of the placenta [6,7,8]. Both nutrient deprivation
and hypoxia stimulate the production of vascular endothelial
growth factor (VEGF) and other angiogenic factors, leading to
protection against ischaemic injury [9,10,11]. Here we report
that the three master regulators of the UPR, IRE1a, PERK and
ATF6a, mediate transcriptional regulation of VEGFA under
ER stress which occurs during normal development of
labyrinthine trophoblast cells in the placenta as well as in
cancer cells.
Results
VEGFA Expression Is Increased by ER Stress
Vascular endothelial growth factor isoform A (VEGFA) is the
most abundant variant of the VEGF family. Previous studies have
shown that VEGFA is upregulated in human retinal ARPE-1 cells
when treated with tunicamycin, an ER stress inducer [12]. To
determine whether VEGFA expression is increased by other ER
stress inducers in other cell types including cancer cells, we treated
prostate cancer cell line, PC-3 (Figure 1A), liver cancer cell line,
HepG2 (Figure 1B), and the insulinoma cells, INS-1 832/13
(Figure 1C), with two ER stress inducers, thapsigargin and
tunicamycin for 4 hr. We found that VEGFA mRNA expression
was increased 2–5 fold by ER stress. We confirmed that these cells
were under ER stress by measuring expression levels of typical ER
stress markers, spliced XBP-1 and BiP.
Figure 1. VEGFA mRNA expression is induced by ER stress. Expression levels of VEGFA, Spliced Xbp1 and BiP were measured by quantitative
PCR in PC3 cells, HepG2 cells and INS-1 832/13 cells following treatment with thapsigargin (Tg, 1 mM), tunicamycin (Tm, 5 mg/ml) and untreated (UT)
control for 4 hr (n = 3, values are mean 6 SD).
doi:10.1371/journal.pone.0009575.g001
Regulation of VEGF-A by UPR
PLoS ONE | www.plosone.org 2 March 2010 | Volume 5 | Issue 3 | e9575
HIF1a Is Not Involved in ER Stress-Mediated VEGFA
Induction
HIF1a is a major regulator of VEGFA mRNA expression
under hypoxia [13]. To test if HIF1a is also involved in ER
stress-mediated VEGF mRNA induction, we treated HepG2
cells with either the ER stress inducer thapsigargin or hypoxia,
and then measured HIF1a protein expression. HIF1a protein
expression by thapsigargin treatment was much lower than
that by hypoxia (Figure 2A), raising the possibility that HIF1a
is not involved in ER stress-mediated VEGFA induction. To
test this possibility, we knocked down HIF1a expression using
siRNA directed against HIF1a in HepG2 cells, stimulated
them with thapsigargin, and then measure VEGFA induction.
As we predicted, siRNA-mediated knockdown of HIF1a did
not affect VEGFA induction by thapsigargin (Figure 2B).
These results strongly suggest that HIF1a is not a major
regulator of VEGFA mRNA expression under ER stress
conditions.
IRE1a Regulates VEGFA under ER Stress Conditions via
XBP-1 Splicing
IRE1a, a key regulator of the UPR, is involved in transcrip-
tional regulation of genes upregulated by ER stress. It has been
shown that IRE1a signaling is involved in VEGFA mRNA
expression by glucose deprivation and hypoxia [5]. Glucose
deprivation is known to activate the UPR. We were therefore
interested in determining whether IRE1a was required for
VEGFA mRNA expression under ER stress conditions. VEGFA
mRNA expression levels were significantly decreased in Ire1a2/2
mouse embryonic fibroblasts (MEFs) as compared to those in
control wild-type MEFs under various ER stress conditions
induced by thapsigargin (Figure 3A), tunicamycin (Figure 3B),
and hypoxia (0.5% O2) (Figure 3C). ER stress during hypoxia was
confirmed in wild-type MEFs by measuring upregulation of spliced
Xbp-1 which was absent in Ire1a2/2 cells (Figure 3C, right panel).
It has been shown that IRE1a is involved in the degradation of
mRNAs encoding secretory proteins [14,15][16][17]. To deter-
Figure 2. Hif1a is not required for VEGFA induction under ER stress. (A) HepG2 cells were treated with either thapsigargin (Tg, 1 mM) 5 hr or
hypoxia (0.5% O2) for 24 hrs. Nuclear lysates were extracted and analyzed using anti-Hif1a and anti-Xbp1 antibodies. Spliced Xbp1 (55 kD) band is
shown here. (B) HepG2 cells were transfected with scramble (Control) or Hif1a siRNA. 18 hrs post-transfection, cells were treated with thapsigargin
(Tg, 1 mM) for 4 hrs. Total mRNA was collected and expression levels of Hif1a and VEGFA were measured by quantitative PCR (n = 3, values are mean
6 SD).
doi:10.1371/journal.pone.0009575.g002
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Figure 3. ER stress-induced VEGFA expression depends on Ire1. (A–C) WT and Ire1a2/2 mouse embryonic fibroblasts (MEFs) were treated
with ER stress inducers thapsigargin (Tg, 1 mM) 5 hr, tunicamycin (Tm, 5 mg/ml) 5 hr and hypoxia (0.5% O2) for 24 hr. Total mRNA was collected and
VEGFA and spliced Xbp1 expression levels were measured by quantitative PCR (n = 3, values are mean 6 SD). (D) Ire1a2/2 MEFs were stably
transduced with LV/Ire1a or LV/GFP, a lentivirus constitutively expressing Ire1a or GFP. These cells along with WT and Ire1a2/2 MEFs were treated
Regulation of VEGF-A by UPR
PLoS ONE | www.plosone.org 4 March 2010 | Volume 5 | Issue 3 | e9575
mine whether IRE1a is involved in VEGFA mRNA stability
under ER stress conditions, we used actinomycin D to attenuate
mRNA transcription, then challenged Ire1a2/2 and control cells
with thapsigargin to induce VEGFA mRNA degradation. We
found that IRE1a was not involved in ER stress-mediated VEGFA
mRNA decay (Figure S1). To further confirm the relationship
between IRE1a signaling and VEGFA mRNA induction, we
established Ire1a2/2 cells transduced with lentivirus expressing
human IRE1a. Ire1a2/2 cells rescued with human IRE1a could
activate XBP-1 splicing, indicating that ectopically expressed
IRE1a was functional (Figure 3D). In Ire1a2/2 cells rescued
human IRE1a, VEGFA mRNA expression was restored under
ER stress conditions (Figure 3E). IRE1a-mediated induction of
VEGFA mRNA also enhanced VEGFA protein production as
well as VEGFA secretion (Figure 3F).
IRE1a mediates XBP-1 mRNA splicing, which leads to
production of an active transcription factor XBP-1-p, raising the
possibility that XBP-1-p was involved in the regulation of VEGFA
mRNA expression under ER stress conditions. To test this idea,
we measured expression levels of VEGFA in Ire1a2/2 MEFs
transfected with mouse processed-XBP1 plasmid. Ectopic expres-
sion of XBP-1-p restored VEGFA induction in Ire1a2/2 MEFs
under ER stress conditions (Figure 3G, left panel). Although
expression levels of VEGFA and spliced XBP-1 were lower in
Ire1a2/2 MEFs ectopically expressing XBP-1p and IRE1a as
compared to control wild-type MEFs, the degree of VEGFA
mRNA induction was strongly correlated with an increase in
spliced Xbp1 mRNA expression (Figure 3G), suggesting that XBP-
1-p-mediated induction of VEGFA is dose-dependent. To further
confirm this idea, we compared expression levels of VEGFA in
HepG2 cells transfected with siRNA directed against IRE1a,
XBP-1, or control scramble siRNA under ER stress induced by
thapsigargin. As we predicted, VEGFA mRNA induction was
attenuated in the cells transfected with IRE1a siRNA and Xbp1
siRNA as compared to the cells transfected with control scramble
siRNA (Figure 3H). Suppression of IRE1 and XBP1 signaling was
confirmed by the downregulation of EDEM, which is a known
downstream effector of XBP-1 [18].
The VEGFA promoter region contains one putative XBP-1-p
binding site, the ACGT core [19,20], 972 bp upstream of the
mouse VEGFA start site, raising the possibility that XBP-1-p binds
to VEGFA promoter. To test this idea, we derived a reporter
construct by cloning 1 kb upstream sequences of the mouse
VEGFA transcription start site upstream of the luciferase gene.
Ectopic XBP-1-p expression increased activity of VEGFA
promoter-luciferase (Figure 3I). In order to determine direct
interaction of XBP1 with VEGFA, we did a chromatin
immunoprecipitation (ChIP) analysis of the mouse VEGFA
promoter. Mouse neuro2A cells either mock transfected or
transfected with XBP-1-p, were treated with thapsigargin. ChIP
analysis indicates that XBP-1-p was recruited to the mouse
VEGFA promoter under ER stress conditions in vivo (Figure 3J).
XBP-1-p overexpression improves binding efficiency which is
further increased by ER stress thus supporting the idea of dose-
dependent upregulation of VEGFA transcription under ER stress.
Collectively, the results of Figure 3 show that VEGFA is a direct
target of the IRE1a-XBP-1 pathway.
IRE1a Regulates VEGFA Expression in Labyrinthine
Trophoblast Cells
Our group and others have previously reported that Ire1a2/2
mice are embryonic lethal by embryonic day 12.5 [21,22,23]. It
has been reported that the embryonic lethality of Ire1a2/2 mice is
due to the defect in the development of the labyrinthine
trophoblast cells which are critical for integration and exchange
between fetal and maternal blood vessels in the placenta [23]. It
has previously been shown that loss of a single Vegfa allele in mice
can result in embryonic lethality by embryonic day 11.5 due to a
defect in the development of labyrinthine trophoblast cells [24].
We therefore considered the possibility that IRE1a has a role in
the survival of labyrinthine trophoblast cells through the activation
of VEGFA expression. As reported previously, we found that
Ire1a2/2 placentas failed to develop proper labyrinthine tropho-
blast on embryonic day 10.5 (Figure 4A). Because of the
progressive loss of blood vessels in the labyrinthine layer, Ire1a2/
2embryos were comparatively smaller in size than wild-type
embryos and did not survive more than embryonic day 12.5
(Figure 4B and Table 1). To confirm the role of IRE1a signaling in
mouse labyrinthine trophoblast cells, we also analyzed the mouse
labyrinthine trophoblast cell line, SM10 [25]. These cells
responded robustly to ER stress inducers, tunicamycin and
thapsigargin as well as 2-deoxy glucose which causes glucose
deprivation, as indicated by upregulation of spliced Xbp1 and
Chop protein expression levels (Figure 4C, left panel). VEGFA
mRNA was also induced significantly upon ER stress (Figure 4C,
right panel). During embryonic development, HIF1a is activated
in the growing placenta [8]. To confirm that HIF1a was not
involved in ER stress-mediated VEGFA mRNA induction in
SM10 cells, we knocked down HIF1a expression by siRNA and
measured VEGFA mRNA expression. As expected, RNAi-
mediated knockdown of HIF1a did not affect VEGFA mRNA
induction by thapsigargin treatment in SM10 cells (Figure 4D).
We next sought to verify that ER stress-mediated VEGFA
mRNA induction required IRE1a in SM10 cells. We transduced
SM10 cells with lentivirus expressing a kinase inactive K599A
mutant form of IRE1a, which has been reported to act as a
dominant-negative of wild-type IRE1a [16,26,27], or GFP as a
with thapsigargin (Tg, 1 mM) for 5 hrs. Cytoplasmic lysates were analyzed using anti-Ire1a and anti-phosphorylated activated Ire1a (P-Ire1a)
antibodies. Nuclear lysates were extracted and analyzed by anti-Xbp1 to show rescue of Ire1 signaling pathway (55 kD spliced form shown here) and
anti-CHOP antibodies. (E) Total mRNA from (D) was analyzed for VEGFA and spliced Xbp1 expression levels (n = 3, values are mean 6 SD). (F) WT,
Ire1a2/2 and Ire1a2/2 rescued MEFs were kept in media with or without glucose for 24 hrs. Supernatant medium as well as whole cell lysates were
collected and analyzed for VEGF protein concentration by ELISA. (G) Ire1a2/2 MEFs transfected with processed-Xbp1 along with WT, Ire1a2/2 and
Ire1a2/2 MEFs overexpressing Ire1a protein were treated with thapsigargin (Tg, 1 mM) for 5 hrs. Total mRNA was analyzed for VEGFA and spliced
Xbp1 expression levels (n = 3, values are mean 6 SD). (H) HepG2 cells were transfected with scramble (Control), Ire1 siRNA or Xbp1 siRNA. 18 hrs
post-transfection, cells were treated with thapsigargin (Tg, 1 mM) for 4 hr. Total mRNA was collected and VEGFA, spliced Xbp1, IRE1a and EDEM
expression levels were measured by quantitative PCR (n = 3, values are mean 6 SD). (I) Luciferase activity in 293T cells transfected with VEGFA-
promoter reporter (pGL3/VEGF21039/0) or control pGL3 mock constructs along with indicated proteins and control PCDNA3 vector (values are mean
6 SD). Xbp1-p represents spliced constitutively active form of Xbp1 transcription factor. Bottom diagram shows schematic of mouse VEGFA gene as
well as size of mouse VEGFA promoter construct. (J) Chromatin IP in Mouse neuro2a cells transfected with either mock pFlag-CMV-2 or processed-
Xbp1 constructs and treated with or without thapsigargin (Tg, 1 mM) for 6 hrs was analyzed using quantitative PCR. PCR primer pair corresponded to
mouse VEGFA promoter segment. Fold enrichment was quantified using ratio of amplification of PCR product relative to 10% input DNA. Value
obtained from mock was defined as 1(n = 3, values are mean 6 SD).
doi:10.1371/journal.pone.0009575.g003
Regulation of VEGF-A by UPR
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Figure 4. Ire1a2/2 mouse labyrinthine placenta defect is due to Ire1-dependent VEGFA expression. (A) WT and Ire1a2/2 placenta were
collected at d10.5 and vertically dissected and HE stained to show all placenta layers from maternal decidua to fetal chorionic plate SP= Spongiotrophoblast,
LA= Labyrinthine trophoblast. (B) WT and Ire1a2/2 embryo littermates were collected from Ire1a+/2 females mated with Ire1a+/2 males. Ire1a2/2
animals die by embryonic day 10.5. (C) Labyrinthine trophoblast SM10 cells were treated with thapsigargin (Tg, 1 mM) tunicamycin (Tm, 5 mg/ml) or 2-Deoxy-
glucose (2 DG) for 6 hrs. Total cell lysates and mRNA were collected. Lysates were analyzed by anti-Xbp1 showing the spliced active 55KD band, and anti-
CHOP antibody (left panel). Total mRNA was used for expression analysis of VEGFA (right panel) (n=2, values are mean6 SD). (D) SM10 cells were transfected
with scramble (Control) or Hif1a siRNA. 18 hrs post-transfection, cells were treated with thapsigargin (Tg, 1 mM) for 4 hrs. Total mRNA was collected and
expression levels of HIF1a and VEGFA were measured by quantitative PCR (n=3, values are mean6 SD). (E) SM10 cells were stably transduced with either LV/
control GFP or LV/Ire1KA mutant lentivirus to constitutively express GFP or Ire1KA protein. Transduced stably expressing cells were kept in media with or
without glucose for 24 hrs. Total mRNA was then analyzed for VEGFA, spliced XBP1 and CHOP expression (n=2, values are mean 6 SD).
doi:10.1371/journal.pone.0009575.g004
Regulation of VEGF-A by UPR
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control, then we induced physiological ER stress using glucose
deprivation which normally occurs during placenta development
[6,7,8]. In cells expressing kinase inactive K599A mutant form of
IRE1, VEGFA mRNA levels were decreased as compared to
control cells expressing GFP (Figure 4E). The suppression of
IRE1a signaling by the kinase inactive IRE1a K599A mutant was
confirmed by the attenuation of XBP-1 splicing (Figure 4E).
Collectively, these results indicate that Ire1 has an essential
function in VEGFA expression in the labyrinthine trophoblast cells
which is independent of HIF1a activity.
ER Stress-Induced VEGFA Upregulation Is Also
Dependent on PERK
As described above, IRE1a-XBP-1 signaling plays a role in the
induction of VEGFA mRNA under ER stress conditions.
However, the lack of IRE1a only partially attenuated VEGFA
mRNA induction. Therefore, it is possible that other components
of the UPR also play a role in VEGFA mRNA expression. To test
this idea, we next sought to study the role of PERK signaling in
VEGFA mRNA expression.
In Perk2/2 MEFs, VEGFA mRNA induction by thapsigargin
treatment was significantly attenuated as compared to wild-type
MEFs (Figure 5A). To confirm that the decreased expression of
VEGFA was due to lack of Perk expression, we analyzed the effect
of Perk-rescue in Perk2/2 cells. We transduced Perk2/2MEFs with
lentivirus expressing PERK. To confirm that ectopically expressed
PERK was functional, we treated the rescued cells along with wild-
type and Perk2/2 parental cells with thapsigargin and measured
ATF4 and CHOP protein expression, two proteins regulated by
PERK. As expected, ATF4 and CHOP protein expression levels
were restored in the rescued cells (Figure 5B). VEGFA mRNA
expression levels were also restored to wild-type levels under ER
stress conditions in the rescued cells (Figure 5C). VEGF protein
expression as well as secretion were also restored in the rescued
cells (Figure 5D).
Previous studies have shown ATF4 translation is dependent on
PERK and suggested that ATF4 plays a role in VEGF mRNA
expression under oxidative stress [28,29]. These considerations
prompted us to investigate the role of ATF4 in VEGFA mRNA
expression under ER stress conditions. We measured VEGFA
mRNA expression in Atf42/2 MEFs and wild-type MEFs.
Figure 5E shows that VEGFA mRNA levels were attenuated in
Atf42/2 cells as compared to wild-type cells.
To further confirm the role of the PERK-ATF4 pathway in
VEGFA mRNA induction, we transfected HepG2 cells with
siRNAs directed against PERK and ATF4 and then measure
VEGFA mRNA expression under ER stress conditions. RNAi-
mediated knockdown of PERK and ATF4 in HepG2 cells resulted
in a significant decrease of VEGFA mRNA expression (Figure 5F
and G).
ATF4 has been previously shown to interact with first intron of
the human VEGFA gene under oxidative stress conditions caused
by arsenite treatment [28]. ATF4 interacts with an amino-acid
response element (AARE) present in the intron. We therefore
considered the possibility that ATF4 binds to the first intron of
VEGFA gene under ER stress conditions.
To test this idea, a reporter plasmid carrying a 3.3 Kb fragment
of intron 1 of the mouse VEGFA gene was cloned into pGL3
luciferase vector. Ectopic ATF4 expression, but not XBP-1,
increased the activity of the reporter (Figure 5H). ChIP analysis
was performed on neuro2A cells in order to confirm the
interaction. The ChIP PCR product comprised of 109 bp starting
from +1581 of the 2891 bp mouse VEGFA intron1.The ChIP
experiments revealed that following addition of thapsigargin,
ATF4 was recruited to the VEGFA intron 1 (Figure 5I).
Collectively, these results indicate that the PERK-ATF4 pathway
directly regulates VEGFA mRNA expression through intron 1 of
VEGFA gene under ER stress condtions.
ATF6a Also Plays a Role in VEGFA mRNA Upregulation
under ER Stress
ATF6a, an ER transmembrane protein, is another upstream
component of the UPR. Under ER stress conditions ATF6a
translocates from ER to the Golgi where its cytoplasmic domain is
cleaved from the membrane to produce a potent transcription
factor regulating UPR target genes [30]. XBP-1 is one of the
targets of cleaved-ATF6a [31]. Hence, we tested the possibility if
ATF6a was involved in VEGFA mRNA expression under ER
stress conditions. As predicted, RNAi-mediated knockdown of
ATF6a in HepG2 cells resulted in a significant decrease of
VEGFAmRNA expression under ER stress conditions (Figure 6A).
To further establish a relationship between ATF6a and VEGFA
mRNA induction, we tested if ATF6a could increase the activity
of gene regulatory regions of VEGFA gene. Ectopic expression of
cleaved active ATF6a increased the activity of VEGFA-promoter
reporter (Figure 6B), but not VEGFA-intron reporter (Figure 6C).
Collectively, these results strongly suggest that ATF6a also plays
role in VEGFA mRNA induction by binding its promoter under
ER stress conditions.
Discussion
Our results indicate that the UPR is activated not only by ER
stress but also deprivation of nutrients and oxygen, and robustly
regulates VEGFA mRNA expression. The regulation of VEGFA
by ER stress is mediated by UPR master regulators, IRE1a,
PERK and ATF6a via their respective transcription factors, XBP-
1, ATF4 and cleaved-ATF6 respectively (Figure 7). Our results
show that VEGFA induction by ER stress is independent of the
hypoxia inducible factor 1 (HIF-1) pathway, a major signaling
pathway for VEGFA induction by hypoxia [13] or there is a cross-
talk between the XBP-1, ATF4, ATF6a, and HIF-1 pathways.
The robust induction of VEGFA by IRE1a signaling is also
important for the development and survival of labyrinthine
trophoblast cells in the placenta.
VEGFA is the major vascular endothelial growth factor and
plays prominent roles in angiogenesis [32]. Angiogenesis is crucial
to many physiological and pathological processes including
development of labyrinthine trophoblast cells in the placenta
[24,33,34]. Mammalian placenta is a vital secretory organ
characterized by secretion of large amounts of diverse proteins
like placental lactogens, proliferins and other growth factors
Table 1. Mouse embryo survival data.
Age (days) Total No. Ire1a +/+ Ire1a +/2 Ire1a 2/2 Resorbed
E 8.5 35 4 (11%) 21 (60%) 8 (23%) 2
E 9.5 34 8 (24%) 19 (56%) 4 (12%) 3
E10.5 84 19 (23%) 45 (54%) 15 (18%) 5
E11.5 34 8 (24%) 17 (50%) 6 (18%) 3
E12.5 33 7 (21%) 14 (42%) 2 (6%)a 10
E13.5 25 6 (24%) 14 (56%) 2 (8%) 3
Ire1+/2 heterozygous animals were crossed and embryos as well as placenta
were collected at various stages of development starting at embryonic day 8.5.
doi:10.1371/journal.pone.0009575.t001
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Figure 5. ER stress induced VEGFA upregulation is also dependent on Perk. (A) WT and Perk2/2 MEFs were treated with thapsigargin (Tg,
1 mM) for 5 hrs. Total mRNA was collected and VEGFA expression levels were measured by quantitative PCR (n = 3, values are mean6 SD). (B) Perk2/
2 MEFs were stably transduced with LV/Perk, a lentivirus constitutively expressing Perk. These cells along with WT and Perk2/2 MEFs and treated
with thapsigargin (Tg, 1 mM) for 5 hrs. Cytoplasmic protein lysates were extracted and analyzed by immunoblot using anti-Perk antibody. Nuclear
protein lysates were analyzed by immunoblot using anti-ATF4 and anti-Chop antibodies to show rescue of Perk signaling pathway. (C)Total mRNA
Regulation of VEGF-A by UPR
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required for the growing embryo. In mice, the placenta is formed
by fusion of the embryo-derived allantois (i.e., umbilical cord) and
the extra-embryonic chorion which derives from the polar
trophectoderm overlying the embryo. Chorioallantoic attachment
at embryonic day 8.5 causes chorionic trophoblast to differentiate
into various layers of labyrinthine trophoblast cells. These
labyrinthine trophoblast cells undergo extensive villus branching
to form the labyrinth by embryonic day 10.5 [34]. The formation
of this layer is critical for integration and exchange between fetal
and maternal blood vessels [6,33]. It has been reported that
hypoxia and nutrient deprivation, which have been shown to
activate both IRE1a and PERK in this study, are involved in
various stages of placental development, one of them being
trophoblast differentiation [6,7,8]. Our results suggest that the
generation of a fully functional labyrinthine trophoblast requires a
coordinated action of downstream effectors regulated by IRE1a
including VEGFA which is independent of HIF1a signaling.
Angiogenesis is crucial for sustaining tumors. IRE1a signaling is
known to be essential for angiogenesis and growth of tumor cells
through VEGFA induction [3,5]. PERK signaling also has been
shown to be important for survival of tumor cells [35]. Our data
show that the IRE1a-XBP-1, PERK-ATF4, and ATF6a pathways
can independently regulate VEGFA mRNA expression under ER
stress conditions via different regulatory regions of the VEGFA
gene. Our results show that both VEGFA promoter as well as the
intron is engaged simultaneously by UPR effectors under ER stress
conditions. This tells us that coordinated activation of all three
regulators is essential for proper upregulation of VEGFA mRNA
expression. Inactivation or knockdown of any of these three master
regulators impairs VEGFA upregulation under ER stress.
Many downstream target genes of the UPR are co-regulated by
IRE1a, PERK, and ATF6a, ensuring the redundancy and
robustness of this adaptive response. However, this biological
design that mediates robustness also has drawbacks. In cancer
cells, VEGFA induction mediated by the UPR is used to maintain
abnormal ER homeostasis and help these cells to survive and
proliferate under chronic ER stress conditions caused by nutrient
deprivation and hypoxia. Thus, inhibiting IRE1a, PERK, and
ATF6a is a promising novel therapeutic modality for cancer
treatment.
Materials and Methods
Cell Culture
Hepatocellular cell line, HepG2, and human prostate cancer
cell line, PC3, were obtained from ATCC. HepG2 was
maintained in MEM with supplements according to ATCC cell
culture instructions. PC3 was maintained in DMEM with 10%
FBS. Rat insulinoma cells, INS-1 832/13, were a gift from Dr.
Christopher Newgard (Duke University Medical Center) and
cultured in RPMI 1640 supplemented with 10% FBS. Ire1a2/2
and Perk2/2 mouse embryonic fibroblasts were gifts from Dr.
David Ron (New York University School of Medicine) and
maintained in DMEM 10% FBS. Mouse labyrinthine trophoblast
SM10 cells were a gift from Dr. Joan Hunt (University of Kansas)
and maintained in RPMI 1640 supplemented with 2 mM
glutamine, 1% sodium pyruvate, 561025 M 2-Mercaptoethanol
and 10% FBS. Human embryonic kidney 293T cells and Mouse
neuro2a cells were obtained from ATCC and maintained in
DMEM with 10% FBS.
Plasmids
Mouse Atf4, mouse Xbp1-processed, mouse Perk, human Ire1a
and human Ire1aKA (K599A) dominant-negative kinase mutant
plasmids were provided by Dr. David Ron (New York University
School of Medicine). Mouse ATF5 plasmid was a gift from Dr.
Michael Green (University of Massachusetts Medical School).
Cleaved processed ATF6(n373) plasmid was provided by Dr. R.
Prywes (Columbia University).
Lentivirus System
Lentivirus expressing human IRE1a, human IRE1aKA and
mouse Perk and GFP were generated by subcloning these
fragments into lentiviral expression plasmid, pLenti-CMV/TO
(Dr. Eric Campeau at the University of Massachusetts Medical
School). Lentivirus was produced in HEK293T cells by transfec-
tion using Lipofectamine2000 (Invitrogen Carlsbad, CA). Lenti-
viral supernatant was collected 48 hours after transfection, and
stored at 280uC. Details of this lentivirus system were described
previously [36]. Ire1a2/2 and Perk2/2 cells were infected with
human IRE1a and mouse Perk lentivirus respectively and selected
with puromycin 2 mg/ml to generate stable cell lines. SM10 cells
were infected with human IRE1aKA and control GFP lentivirus
and selected with Puromycin 1 mg/ml to generate stable cell lines.
siRNA and Plasmid Transfection
Small interfering RNA (siRNA) was transfected using the
Nucleofector Device (Amaxa Biosystems, Gaithersburg, MD) into
HepG2 cells according to manufacturer recommendations.
Human HIF1-a smart pool siRNA was obtained from Dharma-
con, (Lafayette, CO). SiRNAs directed against human PERK,
human IRE1a, human ATF4 and human XBP1 were synthesized
by IDT (Coralville, IA): for human PERK: CCAGAGAAGTGG-
CAAGAAA; for human IRE1: AGACAGAGGCCAAGAGCAA;
for human ATF4: GCAAAGAGCTGGAAAAGAA; for human
XBP1: GGTATTGACTCTTCAGATT. Cells were incubated in
media for overnight after siRNA transfection, and then put under
ER stress conditions. Mouse XBP1-processed plasmid was
transfected using the Nucleofector device (Amaxa Biosystems,
Gaitherburg, MD) into mouse embryonic fibroblasts according to
manufacturer recommendations.
from (B) was analysed for VEGFA and ATF4 expression levels (n = 3, values are mean6 SD). (D) WT, Perk2/2 and Perk2/2 rescued MEFs were kept in
media with or without glucose for 0, 24 and 48 hrs. Supernatant medium as well as whole cell lysates were collected and analyzed for VEGF protein
concentration by ELISA. (E) ATF42/2 MEFs were treated with thapsigargin (Tg, 1 mM) for 4 hrs. Total mRNA was collected and VEGFA expression
levels were measured by quantitative PCR (n = 3, values are mean 6 SD). (F) HepG2 cells were transfected with scramble (Control) and Perk siRNA.
18 hrs post-transfection, cells were treated with thapsigargin (Tg, 1 mM) for 4 hr. Total mRNA was collected and VEGFA, PERK and ATF4 expression
levels were measured by quantitative PCR (n = 3, values are mean 6 SD). (G) HepG2 cells were transfected with scramble (Control) and ATF4 siRNA
and treated with thapsigargin (Tg, 1 mM) for 4 hr. Total mRNA was collected and VEGFA and ATF4 expression levels were measured by quantitative
PCR (n = 3, values are mean 6 SD). (H) Luciferase activity in 293T cells transfected with mouse VEGFA-intron 1 reporter (pGL3/VEGF0/+3351) or control
pGL3 mock constructs along with indicated proteins and control PCDNA3 vector (values are mean6 SD). Bottom diagram shows schematic of mouse
VEGFA gene as well as size of mouse VEGFA- intron construct. (I) Chromatin IP in Mouse neuro2a cells treated with or without thapsigargin (Tg, 1 mM)
for 6 hrs was analyzed using quantitative PCR. PCR primers corresponded to mouse VEGFA-intron 1 genomic region. Fold enrichment was quantified
using ratio of amplification of PCR product relative to 10% input DNA. Value obtained from mock was defined as 1(n = 3, values are mean 6 SD).
doi:10.1371/journal.pone.0009575.g005
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Western Blotting
Cells were lysed in M-PER (Pierce, Rockford IL) for whole cell
protein extraction, or NE-PER (Pierce, Rockford IL) for nuclear
and cytoplasmic protein extraction, after adding protease inhibitor
(Sigma, Saint Louis, MO) according to supplier protocol. Lysates
were run on a 4%–20% linear gradient SDS-PAGE (BioRad,
Hercules, CA) gel. Anti-Atf4 (anti-CREB-2 H-290), Anti-Xbp1,
anti- CHOP/GADD153 and anti-Actin antibodies were obtained
from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-Ire1a,
anti-Perk antibodies was obtained from Cell Signaling (Danvers,
MA). Anti-Hif1a, Anti-phospho Ire1 antibodies was obtained from
Novus Biologicals (Littleton, CO).
Quantitative Polymerase Chain Reaction
Total RNA was isolated from the cells by using the RNeasy
Mini Kit (Qiagen, Valencia, CA). 1 mg of total RNA from cells was
reverse transcribed with Oligo-dT primer (Promega, Madison,
WI). For the thermal cycle reaction, the iQ5 system (BioRad,
Hercules, CA) was used at 95uC for 10 min, then 40 cycles at
95uC for 10 sec, and at 55uC for 30 sec. The relative amount for
each transcript was calculated by a standard curve of cycle
thresholds for serial dilutions of cDNA sample and normalized to
the amount of the house-keeping beta-actin levels. The polymerase
chain reaction (PCR) was performed in triplicate for each sample;
all experiments were repeated three times. Power SYBR Green
PCR Master Mix (Applied Biosystems, Foster City, CA) was used
for the quantitative PCR. PCR primer sequences are listed in
Table S1.
mRNA Stability Assay
Cellular mRNA transcription was attenuated by treating cells
with 5 mg/ml Actinomycin D (Sigma A-4262) for 1 hr. followed by
treatment with thapsigargin (0.2 mM) for different times. Total
RNA was collected and quantitative PCR method described above
was employed to measure levels of VEGFA gene transcripts. Time
point zero for each condition was standardized to 1 and the
subsequent rate of degradation of mRNA was measured.
Luciferase Assay
Mouse Vegfa 1 Kb (21039 to 0) promoter and 3.3 Kb Intron
(460 bp Exon 1+2891 bp Intron 1) was cloned from Mouse BAC
clone RP23 (Invitrogen, Carlsbad, CA) into Xho1/HindIII site of
pGL3 luciferase vector (Promega, Madison, WI). 293T cells were
transfected with both reporters as well as mock pGL3 vector along
with Atf4, processed-Xbp1, processed-Atf6 (D373) and Atf5 by
LipofectamineTM 2000 (Invitrogen, Carlsbad, CA). Twenty-four
hrs post-transfection, lysates were prepared using a Luciferase
Assay System kit (Promega, Madison, WI) according to manufac-
turer’s protocol. The light produced from the samples was read by
a standard plate reading luminometer. Each sample was read in
triplicate and normalized against the signal produced from mock
wells. b-galactosidase activity was measured by b-Gal Reporter
Gene Assay, chemiluminescent (Roche Diagnostics, Mannheim,
Germany). The assay was performed independently three times.
Chromatin Immunoprecipitation (ChIP)
Mouse neuro2a cells were transfected with pFlag-CMV-2 and
processed-Xbp1 expression plasmids by LipofectamineTM 2000
(Invitrogen, Carlsbad, CA). After 36 hrs, cells were treated with or
without thapsigargin for further 6 hrs and fixed in 1% formalde-
hyde. Untransfected Neuro2a cells were also treated with or
without thapsigargin for 6 hrs and fixed in 1% formaldehyde
ChIPs were performed using SimpleChIPTM Enzymatic Chroma-
tin IP Kit (Agarose Beads) (Cell Signaling, Danvers, MA) as per
manufacturer’s recommendation. Antibodies against Xbp1 and
ATF4 from Santa Cruz Biotechnology (Santa Cruz, CA) as well as
a negative control, rabbit IgG, were used for ChIP assay. Purified
DNA from cross-linked cells was dissolved in 25 ml TE; 2 ml was
used for PCR. Inputs consisted of 10% chromatin before
immunoprecipitation. Quantitative PCRs were performed as
described in Quantitative polymerase chain reaction section using
following primer sets: for mouse Vegfa promoter, ATTTCCTGG-
GAAAGGGAATTG and TCCACGGCCTCAAAATTATC; for
mouse Vegfa intron 1, GCCACAGTGTGACCTTCAGA and
CGTGGAGAAAGGGAACAGAA.
ELISA
WT, Ire1a2/2, Perk2/2, Ire1 rescued and Perk rescued mouse
embryonic fibroblasts were treated with media without glucose as
indicated. Both supernatant medium as well as whole cell lysates
Figure 6. ATF6 has an active role in ER stress-induced VEGFA upregulation. (A) HepG2 cells were transfected with scramble (Control) and
ATF6 siRNA and treated with thapsigargin (Tg, 1 mM) for 4 hr. Total mRNA was collected and VEGFA and ATF6 expression levels were measured by
quantitative PCR (n = 3, values are mean 6 SD). (B) Luciferase activity in 293T cells transfected with VEGFA-promoter reporter (pGL3/VEGF21039/0) or
control pGL3 mock constructs along with indicated proteins and control pHA vector (values are mean 6 SD). ATF6(D373) represents cleaved
constitutive active form of ATF6 transcription factor. Xbp1-p and ATF5 represent positive and negative controls respectively. (C) Luciferase activity in
293T cells transfected with mouse VEGFA-intron 1 reporter (pGL3/VEGF0/+3351) or control pGL3 mock constructs along with indicated proteins and
control pHA vector (values are mean 6 SD). ATF4 and ATF5 serve as positive and negative controls respectively.
doi:10.1371/journal.pone.0009575.g006
Figure 7. VEGFA expression is regulated by ER stress. ER stress
signaling regulates VEGFA expression via its principal regulators Ire1a,
Perk and ATF6a. Proposed pathway shows how ER stress signaling
might affect growth and survival of both developing placenta as well as
tumor through angiogenesis. This is accomplished by activating VEGFA
transcription via different regulatory regions on the VEGFA gene.
doi:10.1371/journal.pone.0009575.g007
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were collected. Mouse VEGF secreted protein from supernatant
and lysates were measured via ELISA analysis using Bio-Plex 200
System (BioRad, Hercules, CA) at the UMass Mouse Phenotyping
Center at University of Massahusetts Medical School, Worcester,
MA.
Ire1a+/2 Animals
Ire1a+/2 mice on 129 background are maintained at the animal
medicine core at UMass Medical School (Worcester, MA).
Supporting Information
Figure S1 Ire1a does not affect VEGF mRNA stability. WT and
Ire1a2/2 MEFs were treated with or without actinomycin D
(5 mg/ml) for 1 hr. Cells were then treated with ER stress inducer,
thapsigargin (Tg, 1 mM) for 0, 1.5 or 3 hrs. Total mRNA was
collected and expression levels of VEGFA were measured by
quantitative PCR (n= 3, values are mean 6 SD).
Found at: doi:10.1371/journal.pone.0009575.s001 (2.72 MB TIF)
Table S1 Quantitative PCR Primer Sequences. The following
table indicates sets of primers used for quantitative PCR.
Found at: doi:10.1371/journal.pone.0009575.s002 (0.04 MB
DOC)
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